World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
138
Citations
73786
World Ranking
1829
National Ranking
36

Overview

Tiziano Barbui is affiliated with FROM-Fondazione per la Ricerca Ospedale di Bergamo in Italy. Their research primarily focuses on the fields of medicine, with significant contributions in genetics, hematology, rheumatology, molecular biology, and infectious diseases.

The main topics of their work include:

  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Eosinophilic Disorders and Syndromes
  • Acute Myeloid Leukemia Research
  • Kruppel-like factors research
  • Chronic Myeloid Leukemia Treatments
  • Hemoglobinopathies and Related Disorders
  • COVID-19 Clinical Research Studies

Notable recent publications involving Tiziano Barbui are:

  • Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial, 2021, The Lancet Haematology

Other highly cited papers in related research by coauthors include:

  • International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data, 2022, Blood
  • Polycythemia vera: 2024 update on diagnosis, risk-stratification, and management, 2023, American Journal of Hematology
  • Polycythemia vera: historical oversights, diagnostic details, and therapeutic views, 2021, Leukemia
  • JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis, 2021, Blood Cancer Journal

Frequent co-authors collaborating with Tiziano Barbui include:

  • Alessandro M. Vannucchi
  • Paola Guglielmelli
  • Valerio De Stefano
  • Alessandra Carobbio
  • Ayalew Tefferi

Their work is frequently published in venues such as:

  • Blood
  • Blood Cancer Journal
  • American Journal of Hematology
  • Leukemia
  • Blood Advances

Best Publications

  • JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis.

    Claire Harrison;Jean Jacques Kiladjian;Haifa Kathrin Al-Ali;Heinz Gisslinger

  • Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor

    M. Galli;T. Barbui;P. Comfurius;C. Maassen

  • Efficacy and Safety of Low-Dose Aspirin in Polycythemia Vera

    Raffaele Landolfi;Roberto Marchioli;Jack Kutti;Heinz Gisslinger

  • Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature

    Monica Galli;Davide Luciani;Guido Bertolini;Tiziano Barbui

  • Hydroxyurea for Patients with Essential Thrombocythemia and a High Risk of Thrombosis

    Sergio Cortelazzo;Guido Finazzi;Marco Ruggeri;Oscar Vestri

  • Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet

    Tiziano Barbui;Giovanni Barosi;Gunnar Birgegard;Francisco Cervantes

  • Cardiovascular Events and Intensity of Treatment in Polycythemia Vera

    Roberto Marchioli;Guido Finazzi;Giorgina Specchia;Rossella Cacciola

  • Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel.

    Ayalew Tefferi;Juergen Thiele;Attilio Orazi;Hans Michael Kvasnicka

  • Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups.

    Miguel A. Sanz;Francesco Lo Coco;Guillermo Martı́n;Giuseppe Avvisati

  • Vascular and Neoplastic Risk in a Large Cohort of Patients With Polycythemia Vera

    Roberto Marchioli;Guido Finazzi;Raffaele Landolfi;Jack Kutti

  • Survival and prognosis among 1545 patients with contemporary polycythemia vera: An international study

    A Tefferi;E Rumi;G Finazzi;H Gisslinger

  • Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin

    E M Bevers;M Galli;T Barbui;P Comfurius

  • Long-term survival and blast transformation in molecularly-annotated essential thrombocythemia, polycythemia vera and myelofibrosis

    Ayalew Tefferi;Paola Guglielmelli;Dirk R. Larson;Christy Finke

  • The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto

    Paolo Rebulla;Guido Finazzi;Francesca Marangoni;Giuseppe Avvisati

  • A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS).

    G. Finazzi;R. Marchioli;V. Brancaccio;P. Schinco

  • Molecular Remission in PML/RARα-Positive Acute Promyelocytic Leukemia by Combined All-trans Retinoic Acid and Idarubicin (AIDA) Therapy

    Franco Mandelli;Daniela Diverio;Giuseppe Avvisati;Anna Luciano

  • Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome.

    Jason A. Coppell;Paul G. Richardson;Robert Soiffer;Paul L. Martin

  • Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis)

    Tiziano Barbui;Guido Finazzi;Alessandra Carobbio;Juergen Thiele

  • Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia.

    Alessandro M. Vannucchi;Elisabetta Antonioli;Paola Guglielmelli;Alessandro Rambaldi

  • Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia.

    Sergio Cortelazzo;Piera Viero;Guido Finazzi;Anna D'Emilio

Frequent Co-Authors

Alessandro Rambaldi
Alessandro Rambaldi University of Milan
Alessandro M. Vannucchi
Alessandro M. Vannucchi University of Florence
Guido Finazzi
Guido Finazzi Mario Negri Institute for Pharmacological Research
Francesco Passamonti
Francesco Passamonti University of Milan
Paola Guglielmelli
Paola Guglielmelli University of Florence
Giovanni Barosi
Giovanni Barosi University of Pavia
Ayalew Tefferi
Ayalew Tefferi Mayo Clinic
Francisco Cervantes
Francisco Cervantes University of Barcelona
Claire N. Harrison
Claire N. Harrison Guy's and St Thomas' NHS Foundation Trust
Mario Cazzola
Mario Cazzola University of Pavia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine isn't limited to traditional medical school tracks. Many students consider related fields—especially nursing—offering flexible online options and alternative career paths. For those seeking advanced roles in healthcare and research, online phd programs nursing provide a pathway to leadership and academia. These programs typically cater to professionals ready to take their education to the next level while balancing work and life commitments.

If you’re just starting or looking to advance with minimal costs, cheapest rn to bsn online programs offer an affordable way for registered nurses to earn a Bachelor of Science in Nursing, boosting both job opportunities and earning potential.

Not a nurse yet? Some universities offer specialized online msn programs for non nurses designed for graduates of other fields, allowing them to pivot quickly into nursing careers.

Admission standards vary widely. Applicants focused on accessibility and quicker starts can explore the easiest nursing schools to get into, which often have more open admissions processes to support those beginning their healthcare journey.

Best Scientists Citing Tiziano Barbui

Trending Scientists

Recently Published Articles